Showing 20 of 10287 recruiting trials
Efgartigimod for the Treatment of Acute Optic Neuritis
👨⚕️ Anastasia Vishnevetsky, MD, MPH, Massachusetts General Hospital📍 2 sites📅 Started Aug 2025View details ↗
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Study of MAR002 in Healthy Men
RecruitingNCT07264426 ↗
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
RecruitingNCT07312266 ↗
Questioning the Epidemiology of Asymptomatic TB
Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular Hemolysis
Self-balancing Personal Exoskeleton for SCI (WINY)
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Effect of Cross-Education in Blood Flow Restriction Resistance Training on Lower Limbs in Older Women
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women
👨⚕️ Mehnaz K Professor, FCPS, Nishtar Medical University and Hospital📍 1 site📅 Started Aug 2025View details ↗
Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above
Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy
RecruitingNCT07192393 ↗
Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
👨⚕️ David Peereboom, MD, Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute📍 1 site📅 Started Aug 2025View details ↗
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
👨⚕️ Robert Stuver, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Aug 2025View details ↗
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 6 sites📅 Started Aug 2025View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →